Literature DB >> 12127102

Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS.

J -Y Li1, P Henning Jensen, A Dahlström.   

Abstract

Alpha-synuclein is a presynaptic protein that normally participates in the homeostasis of synaptic vesicles. Missense mutations in its gene cause the protein to participate actively in the development of heritable forms of Parkinson's disease. Moreover, its metabolism is perturbed in all cases of Parkinson's disease where alpha-synuclein accumulates in a filamentous form in the Lewy body nerve cell lesion. Lewy bodies also develop in other common neurodegenerative disorders, like dementia with Lewy bodies and Lewy body variant of Alzheimer's disease. In the present study, we have studied the detailed distribution of alpha-, beta- and gamma-synuclein in the rat CNS. Alpha-synuclein was not observed in perikarya, but was distributed with high intensity in nerve terminals in the caudate and putamen and ventral pallidum, where beta-synuclein was much weaker and less densely distributed in the caudate and putamen. Gamma-synuclein was not found in the caudate and putamen. Alpha-synuclein was robustly distributed in the substantia nigra pars reticulata, but was very weak or virtually absent from the perikarya of the neurons in the pars compacta. In contrast, beta-synuclein was very weak or absent from the substantia nigra. gamma-Synuclein was absent from the terminals of substantia nigra pars reticulata, but sparsely distributed gamma-synuclein-containing neurons were detected in the substantia nigra pars compacta. In the brainstem, alpha-synuclein as well as gamma-synuclein were present in the locus coeruleus with high intensity, while beta-synuclein was very weak. In addition, alpha-synuclein was intense in the vagus nucleus, but weak in the oculomotor, facial, hypoglossal, accessory and ambiguous nuclei, where beta-synuclein was very intensely present. Furthermore, gamma-synuclein was localized in the terminals and in cell bodies of the Edinger-Westphal nucleus, the red nucleus, locus coeruleus, and most cranial nerve-related nuclei. In the spinal cord, alpha- and gamma-synucleins were intensely present in laminae I and II and in the preganglionic sympathetic nuclei, whereas beta-synuclein was very weak. These results indicate that alpha-synuclein is abundant in central catecholaminergic regions. Beta-synuclein is more localized in the somatic cholinergic components, while it is particularly weak or absent from catecholaminergic neurons. Gamma-synuclein appears to be present in both cholinergic and catecholaminergic regions, but very weak in the forebrain. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127102     DOI: 10.1016/s0306-4522(02)00143-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  43 in total

1.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

2.  Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.

Authors:  Beate Winner; Edward Rockenstein; D Chichung Lie; Robert Aigner; Michael Mante; Ulrich Bogdahn; Sebastien Couillard-Despres; Eliezer Masliah; Jürgen Winkler
Journal:  Neurobiol Aging       Date:  2007-01-31       Impact factor: 4.673

Review 3.  Innervation of the gastrointestinal tract: patterns of aging.

Authors:  Robert J Phillips; Terry L Powley
Journal:  Auton Neurosci       Date:  2007-05-29       Impact factor: 3.145

4.  Partial regulation of serotonin transporter function by gamma-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

5.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

6.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

Authors:  R J Phillips; G C Walter; S L Wilder; E A Baronowsky; T L Powley
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

7.  Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma.

Authors:  Cui-Qi Zhou; Shuang Liu; Li-Yan Xue; Yi-Hua Wang; Hong-Xia Zhu; Ning Lu; Ning-Zhi Xu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 8.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

9.  α-Synuclein expression in the mouse cerebellum is restricted to VGluT1 excitatory terminals and is enriched in unipolar brush cells.

Authors:  Sun Kyong Lee; Roy V Sillitoe; Coralie Silva; Marco Martina; Gabriella Sekerkova
Journal:  Cerebellum       Date:  2015-10       Impact factor: 3.847

10.  Localization of synucleins in the mammalian cochlea.

Authors:  O Akil; C M Weber; S N Park; N Ninkina; V Buchman; L R Lustig
Journal:  J Assoc Res Otolaryngol       Date:  2008-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.